MedPath

Nutrition and Neurological Development of Very Preterm Infants

Completed
Conditions
Delayed Mental Development
Premature Infant
Infant Nutrition Disorders
Interventions
Other: Premature infants with a GA < 32 weeks
Registration Number
NCT02184650
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The main goal of this study is to determine, in preterm infants born with a GA \< 32 weeks, the association between:

* the quantity of mother's milk and duration and breastfeeding

* the intake of polyunsaturated fatty acids and iron during hospitalizations

Detailed Description

The main hypothesis of this study is that the intake of lipid during hospitalization in neonatology department is associated with neurological development of preterm infants born with a GA \< 32 weeks. The other hypotheses are that iron intake and the duration of breastfeeding are also associated with the development of preterm infants.

In the previous study EPINUTRI (NCT01486173), the development of infants was evaluated until the age of 1 year. EPINUTRI_3 is the follow-up of EPINUTRI until the age of 3 years.

The aim of EPINUTRI_3 study is to determine the association between lipid intake during hospitalization in neonatology department of preterm infants born with a GA \< 32 weeks.

The secondary objective is :

- to evaluate the association between these factors and communication, developmental and social-emotional delays with the test " Ages and Stages questionnaire " (ASQ) at 3 years of age.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
206
Inclusion Criteria
  • Premature infants previously included in EPINUTRI study
  • Non opposition of the parents for the collection of clinical and nutritional data
Exclusion Criteria
  • Refusal of the parents to collect clinical and nutritional data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Premature infantsPremature infants with a GA < 32 weeksPremature infants with a GA \< 32 weeks
Primary Outcome Measures
NameTimeMethod
Neurological developmentAt 3 years of age

Age and Stages Questionnaire

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital Necker Assistance Publique- Hôpitaux de Paris

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath